Oslo, 15 April 2026: Reference is made to the stock exchange announcement by
Navamedic ASA published on 31 March 2026, regarding the company's annual general
meeting being held on 23 April 2026. The nomination committee's recommendation
was not available at the time the notice was distributed but has now been
submitted to the annual general meeting.

The nomination committee has nominated the following persons to members of the
company's board of directors:
- Candidate 1: Morten Jurs nominated as chairperson
- Candidate 2: Rune Wahl nominated as board member
- Candidate 3: Hilde Furberg nominated as board member 
- Candidate 4: Camilla Harder Hartvig nominated as board member
- Candidate 5: Mads Helmich Pedersen nominated as board member
- Candidate 6: Otto Moltke-Hansen nominated as board observer
- Candidate 7: position is intentionally left vacant

In addition, the nomination committee has nominated the following persons as
members of the company's nomination committee:
- Candidate 1: Bård Brath Ingerø nominated as leader
- Candidate 2: Katarina Hammar nominated as member
- Candidate 3: Karianne Melleby nominated as member

The nomination committee's recommendation, including inter alia, information on
proposed remuneration to members of the board of directors, the various board
committees and the nomination committee is attached hereto and will be made
available on the company's website
https://navamedic.com/investors/general-meeting/.

At the annual general meeting, the shareholders will vote on the candidates on
an individual basis in accordance with the Norwegian Code of Practice for
Corporate Governance (NUES). Votes and proxies already submitted will remain
valid, and there is no need to vote again or submit a new proxy as a result of
this announcement.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.